Gormley Glenn bought AKTS
April 15, 2026 · Form 4 insider transaction
Gormley Glenn bought 37,866 shares of Aktis Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
37,866
Price
$0.00
Total value
N/A
InsiderGormley Glenn
RoleDirector
CompanyAktis Oncology, Inc. (AKTS)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 15, 2026
Filing dateApril 16, 2026
Shares owned after37,866
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/3 of the original number of shares subject to the option shall vest on April 15, 2027, and 1/3 of the original number of shares subject to the option shall vest in equal annual installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.